Research Insight LLC   Report issue

For profit Phase 3 Phase 4
Founded: Denver CO United States (1999)

Organization Overview

First Clinical Trial
2020
NCT04342988
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Research Insight LLC

Active Ingredients

Drugs in Phase 4 Trials (3)

cyclosporine (sandimmune) (2 trials)

dexamethasone (1 trial)

lifitegrast (xiidra) (1 trial)

Drugs in Phase 3 Trials (1)

loteprednol (lotemax) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cataract (Phase 4)

Dry Eye Syndromes (Phase 4)

Keratoconjunctivitis Sicca (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 4